Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine + dexamethasone versus bupivacaine alone for post-thoracotomy pain
IRCT20220309054226N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Mar 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of bupivacaine and dexamethasone in Acute post-thoracotomy pain (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Pain. Started Mar 2022; status: completed.
02
Drugs
bupivacainedexamethasone
03
Conditions
Acute post-thoracotomy pain
Beyond the preview
Go deeper on IRCT20220309054226N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220309054226N1.